Lafayette Investments Inc. trimmed its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 5.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,189 shares of the company’s stock after selling 200 shares during the quarter. Lafayette Investments Inc.’s holdings in GE HealthCare Technologies were worth $299,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Quent Capital LLC boosted its position in shares of GE HealthCare Technologies by 18.4% during the 3rd quarter. Quent Capital LLC now owns 766 shares of the company’s stock worth $72,000 after purchasing an additional 119 shares in the last quarter. Greenleaf Trust grew its position in GE HealthCare Technologies by 1.7% in the 3rd quarter. Greenleaf Trust now owns 7,619 shares of the company’s stock valued at $715,000 after purchasing an additional 124 shares during the period. EverSource Wealth Advisors LLC increased its stake in GE HealthCare Technologies by 8.7% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,590 shares of the company’s stock valued at $135,000 after purchasing an additional 127 shares in the last quarter. Quarry LP raised its holdings in GE HealthCare Technologies by 28.3% during the second quarter. Quarry LP now owns 594 shares of the company’s stock worth $46,000 after buying an additional 131 shares during the last quarter. Finally, Tempus Wealth Planning LLC raised its holdings in GE HealthCare Technologies by 0.5% during the second quarter. Tempus Wealth Planning LLC now owns 30,892 shares of the company’s stock worth $2,407,000 after buying an additional 141 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at GE HealthCare Technologies
In other news, CEO Thomas J. Westrick sold 2,750 shares of GE HealthCare Technologies stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the sale, the chief executive officer now directly owns 17,509 shares in the company, valued at approximately $1,414,377.02. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.27% of the stock is owned by company insiders.
Analysts Set New Price Targets
View Our Latest Research Report on GE HealthCare Technologies
GE HealthCare Technologies Stock Performance
GE HealthCare Technologies stock traded up $0.24 during midday trading on Thursday, hitting $89.53. The stock had a trading volume of 102,173 shares, compared to its average volume of 2,990,408. The company has a current ratio of 1.06, a quick ratio of 0.82 and a debt-to-equity ratio of 1.05. GE HealthCare Technologies Inc. has a 52-week low of $62.35 and a 52-week high of $94.55. The company has a market capitalization of $40.87 billion, a PE ratio of 26.11, a P/E/G ratio of 3.39 and a beta of 1.18. The firm’s fifty day moving average is $88.28 and its two-hundred day moving average is $83.41.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last issued its earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.98 by $0.02. The company had revenue of $4.84 billion for the quarter, compared to the consensus estimate of $4.88 billion. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The firm’s quarterly revenue was up .5% on a year-over-year basis. During the same quarter last year, the company earned $0.92 EPS. On average, research analysts forecast that GE HealthCare Technologies Inc. will post 4.26 EPS for the current year.
GE HealthCare Technologies Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a $0.03 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.13%. GE HealthCare Technologies’s payout ratio is 3.51%.
About GE HealthCare Technologies
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Further Reading
- Five stocks we like better than GE HealthCare Technologies
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- A $1.75 Billion Gamble: Can Lucid Ignite Growth?
- How is Compound Interest Calculated?
- The Rally in Lockheed Martin and RTX Can Continue: Here’s Why
- What Are Growth Stocks and Investing in Them
- 3 Undervalued Technology Stocks With Big Rebound Potential
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.